Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-001608
Filing Date
2020-12-22
Accepted
2020-12-22 19:39:49
Documents
1
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 e620162_4-sassine.html 4  
1 e620162_4-sassine.xml 4 4837
  Complete submission text file 0001193805-20-001608.txt   6188
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address
SASSINE ANDY (Reporting) CIK: 0001515322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38942 | Film No.: 201409452

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Issuer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations